Pancreatic Cancer Research

ResearcherSamsung Medical CenterNo recent work listed

Seong Ho Choi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0729-8084; OpenAlex author ID A5100784029. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 3 papers · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 13

  1. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion. Co-author DOI 10.1016/j.asjsur.2020.07.021↗
  2. Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer. First author DOI 10.23736/s0026-4733.19.07958-6↗
  3. Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data. Co-author DOI 10.3389/fonc.2020.01112↗
  4. Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospect… Last author DOI 10.1097/sla.0000000000002705↗
  5. Actual long-term outcome of T1 and T2 pancreatic ductal adenocarcinoma after surgical resection. Co-author DOI 10.1016/j.ijsu.2017.02.007↗
  6. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. Co-author DOI 10.18632/oncotarget.17463↗
  7. Extended versus peripancreatic lymph node dissection for the treatment of left-sided pancreatic cancer. Co-author DOI 10.4174/astr.2017.92.6.411↗
  8. Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00259-016-3316-6↗
  9. Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients. Co-author DOI 10.1007/s00280-013-2328-1↗
  10. Glucagon/insulin ratio in preoperative screening before pancreatic surgery: correlation with hemoglobin A1C in subjects with and without pancreatic cancer. First author DOI 10.1007/s12020-013-0159-9↗
  11. Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer. First author DOI 10.1016/j.actbio.2013.08.046↗
  12. Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/pmic.201200101↗
  13. Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review. Co-author DOI 10.1097/coc.0b013e31821a83d7↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Seok Heo · 8 shared papers, 2012–2021 · strength 0.65
  2. In Woong Han · 3 shared papers, 2017–2021 · strength 0.36
  3. Sunjong Han · 3 shared papers, 2017–2021 · strength 0.36
  4. Yung Hun You · 2 shared papers, 2017–2021 · strength 0.24
  5. Joon Oh Park · 4 shared papers, 2012–2018 · strength 0.18
  6. Dong Wook Choi · 2 shared papers, 2017 · strength 0.16
  7. Jin‐Young Jang · 2 shared papers, 2018–2020 · strength 0.15
  8. Young Suk Park · 4 shared papers, 2012–2017 · strength 0.15
  9. Kwang Hyuck Lee · 3 shared papers, 2012–2017 · strength 0.14
  10. Youngju Ryu · 1 shared paper, 2020 · strength 0.13
  11. Huisong Lee · 1 shared paper, 2017 · strength 0.10
  12. John Bart Rose · 1 shared paper, 2020 · strength 0.09
  13. Geertjan van Tienhoven · 1 shared paper, 2020 · strength 0.09
  14. Francesco Giovinazzo · 1 shared paper, 2020 · strength 0.09
  15. Yuichi Nagakawa · 1 shared paper, 2020 · strength 0.09
  16. Eva Versteijne · 1 shared paper, 2020 · strength 0.09
  17. Scott W. Helton · 1 shared paper, 2020 · strength 0.09
  18. Mark M. Zalupski · 1 shared paper, 2020 · strength 0.09
  19. Chang Moo Kang · 1 shared paper, 2020 · strength 0.09
  20. Casper H.J. van Eijck · 1 shared paper, 2020 · strength 0.09
  21. Mohammad Abu Hilal · 1 shared paper, 2020 · strength 0.09
  22. Soo‐Youn Lee · 2 shared papers, 2012–2017 · strength 0.08
  23. Hyung‐Doo Park · 2 shared papers, 2012–2017 · strength 0.08
  24. Kee‐Taek Jang · 2 shared papers, 2012–2017 · strength 0.08
  25. Jong Kyun Lee · 2 shared papers, 2012–2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.